XORTX Total Assets vs Total Stockholder Equity Analysis

XRTX Stock  USD 1.27  0.06  4.96%   
XORTX Therapeutics financial indicator trend analysis is more than just analyzing XORTX Therapeutics current accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether XORTX Therapeutics is a good investment. Please check the relationship between XORTX Therapeutics Total Assets and its Total Stockholder Equity accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XORTX Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy XORTX Stock please use our How to Invest in XORTX Therapeutics guide.

Total Assets vs Total Stockholder Equity

Total Assets vs Total Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of XORTX Therapeutics Total Assets account and Total Stockholder Equity. At this time, the significance of the direction appears to have almost identical trend.
The correlation between XORTX Therapeutics' Total Assets and Total Stockholder Equity is 0.98. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Total Stockholder Equity in the same time period over historical financial statements of XORTX Therapeutics, assuming nothing else is changed. The correlation between historical values of XORTX Therapeutics' Total Assets and Total Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of XORTX Therapeutics are associated (or correlated) with its Total Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Stockholder Equity has no effect on the direction of Total Assets i.e., XORTX Therapeutics' Total Assets and Total Stockholder Equity go up and down completely randomly.

Correlation Coefficient

0.98
Relationship DirectionPositive 
Relationship StrengthVery Strong

Total Assets

Total assets refers to the total amount of XORTX Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in XORTX Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.
Most indicators from XORTX Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into XORTX Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XORTX Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy XORTX Stock please use our How to Invest in XORTX Therapeutics guide.Selling General Administrative is likely to drop to about 1 M in 2024. Issuance Of Capital Stock is expected to grow at the current pace this year
 2021 2022 2023 2024 (projected)
Reconciled Depreciation17.9K55.5K139.7K146.7K
Research Development669.1K6.5M3.2M1.7M

XORTX Therapeutics fundamental ratios Correlations

0.730.820.98-0.27-0.99-0.580.530.990.90.990.760.63-0.250.891.0-0.35-0.43-0.740.910.61-0.620.560.95-0.150.97
0.730.940.76-0.41-0.72-0.10.120.720.470.720.170.15-0.350.560.74-0.09-0.15-0.280.580.42-0.380.270.60.160.82
0.820.940.8-0.51-0.81-0.240.440.810.60.810.350.24-0.440.770.83-0.09-0.17-0.340.620.54-0.50.370.740.190.84
0.980.760.8-0.23-0.98-0.550.390.980.880.980.710.61-0.190.80.98-0.38-0.45-0.750.920.58-0.580.560.9-0.170.99
-0.27-0.41-0.51-0.230.20.45-0.33-0.21-0.31-0.21-0.14-0.35-0.19-0.31-0.260.210.280.25-0.31-0.570.56-0.52-0.120.19-0.29
-0.99-0.72-0.81-0.980.20.51-0.51-1.0-0.88-1.0-0.73-0.570.28-0.88-0.990.310.380.7-0.89-0.540.54-0.48-0.960.12-0.97
-0.58-0.1-0.24-0.550.450.51-0.49-0.51-0.76-0.51-0.82-0.98-0.44-0.49-0.550.70.770.86-0.78-0.790.84-0.9-0.450.71-0.53
0.530.120.440.39-0.33-0.51-0.490.510.550.510.670.38-0.420.830.52-0.15-0.23-0.30.330.57-0.570.440.660.110.34
0.990.720.810.98-0.21-1.0-0.510.510.881.00.730.57-0.290.890.99-0.3-0.37-0.70.880.53-0.540.480.96-0.110.97
0.90.470.60.88-0.31-0.88-0.760.550.880.880.880.790.050.80.88-0.4-0.48-0.870.920.61-0.630.70.84-0.340.85
0.990.720.810.98-0.21-1.0-0.510.511.00.880.730.57-0.290.890.99-0.3-0.37-0.70.880.53-0.540.480.96-0.110.97
0.760.170.350.71-0.14-0.73-0.820.670.730.880.730.820.00.740.74-0.59-0.65-0.780.780.7-0.720.770.75-0.350.65
0.630.150.240.61-0.35-0.57-0.980.380.570.790.570.820.480.470.6-0.7-0.77-0.910.850.73-0.780.850.48-0.780.6
-0.25-0.35-0.44-0.19-0.190.28-0.44-0.42-0.290.05-0.290.00.48-0.48-0.28-0.3-0.3-0.370.170.02-0.080.29-0.44-0.84-0.15
0.890.560.770.8-0.31-0.88-0.490.830.890.80.890.740.47-0.480.89-0.18-0.27-0.540.680.58-0.580.460.950.080.78
1.00.740.830.98-0.26-0.99-0.550.520.990.880.990.740.6-0.280.89-0.35-0.42-0.710.890.61-0.610.540.95-0.130.97
-0.35-0.09-0.09-0.380.210.310.7-0.15-0.3-0.4-0.3-0.59-0.7-0.3-0.18-0.350.990.49-0.53-0.730.75-0.77-0.210.53-0.36
-0.43-0.15-0.17-0.450.280.380.77-0.23-0.37-0.48-0.37-0.65-0.77-0.3-0.27-0.420.990.58-0.61-0.80.83-0.84-0.280.56-0.43
-0.74-0.28-0.34-0.750.250.70.86-0.3-0.7-0.87-0.7-0.78-0.91-0.37-0.54-0.710.490.58-0.91-0.560.61-0.71-0.610.65-0.73
0.910.580.620.92-0.31-0.89-0.780.330.880.920.880.780.850.170.680.89-0.53-0.61-0.910.65-0.680.70.77-0.530.92
0.610.420.540.58-0.57-0.54-0.790.570.530.610.530.70.730.020.580.61-0.73-0.8-0.560.65-1.00.930.47-0.310.58
-0.62-0.38-0.5-0.580.560.540.84-0.57-0.54-0.63-0.54-0.72-0.78-0.08-0.58-0.610.750.830.61-0.68-1.0-0.94-0.470.39-0.58
0.560.270.370.56-0.52-0.48-0.90.440.480.70.480.770.850.290.460.54-0.77-0.84-0.710.70.93-0.940.39-0.480.54
0.950.60.740.9-0.12-0.96-0.450.660.960.840.960.750.48-0.440.950.95-0.21-0.28-0.610.770.47-0.470.390.020.87
-0.150.160.19-0.170.190.120.710.11-0.11-0.34-0.11-0.35-0.78-0.840.08-0.130.530.560.65-0.53-0.310.39-0.480.02-0.21
0.970.820.840.99-0.29-0.97-0.530.340.970.850.970.650.6-0.150.780.97-0.36-0.43-0.730.920.58-0.580.540.87-0.21
Click cells to compare fundamentals

XORTX Therapeutics Account Relationship Matchups

XORTX Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.1M2.3M17.3M12.3M5.5M5.0M
Other Current Liab641.5K728.4K3.8M151.4K87.6K83.2K
Total Current Liabilities1.3M1.0M4.2M1.5M294.9K280.2K
Total Stockholder Equity(211.7K)1.3M13.1M7.0M4.6M3.1M
Property Plant And Equipment Net731.0341.00.092.5K23.9K28.8K
Net Debt(7.8K)(171.3K)(14.8M)(10.3M)(3.4M)(3.6M)
Retained Earnings(6.8M)(8.0M)(7.6M)(14.1M)(17.9M)(17.0M)
Accounts Payable607.4K305.8K324.0K1.3M195.8K186.0K
Cash58.6K171.3K14.8M10.4M3.4M3.6M
Non Current Assets Total272.7K234.3K1.5M1.5M1.4M731.9K
Cash And Short Term Investments58.6K171.3K14.8M10.4M3.4M3.6M
Net Receivables15.5K14.4K40.7K81.8K60.7K35.1K
Common Stock Shares Outstanding595.5K740.4K1.1M1.5M2.0M2.1M
Liabilities And Stockholders Equity1.1M2.3M17.3M12.3M5.5M5.0M
Other Stockholder Equity683.0K0.0(1.4M)(2.4M)5.5M5.8M
Total Liab1.3M1.0M4.2M5.4M825.9K784.6K
Total Current Assets815.2K2.1M15.8M10.9M4.1M4.2M
Short Long Term Debt Total272.5K43.3K50.8K77.4K11.5K10.9K
Intangible Assets272.4K234.3K201.0K199.4K175.3K189.0K
Net Tangible Assets(484.1K)1.0M16.5M9.2M10.6M11.1M
Net Invested Capital(160.9K)1.3M16.7M7.0M4.6M4.6M
Net Working Capital(484.5K)1.0M14.9M9.4M3.8M4.3M
Other Current Assets741.2K2.1M1.0M379.6K560.4K728.6K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for XORTX Stock Analysis

When running XORTX Therapeutics' price analysis, check to measure XORTX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XORTX Therapeutics is operating at the current time. Most of XORTX Therapeutics' value examination focuses on studying past and present price action to predict the probability of XORTX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XORTX Therapeutics' price. Additionally, you may evaluate how the addition of XORTX Therapeutics to your portfolios can decrease your overall portfolio volatility.